In lung cancer, overexpression of PFKL (phosphofructokinase) has been found to promote cell growth, colony formation, and decrease cellular ATP content, while also predicting poor overall survival (Yang et al., 2016). This evidence concerns the gene PFKL and lung carcinoma.